… into clinical development and further advance our novel Axiomer ® RNA editing platform. With these events we look … or halt corneal degeneration in patients with FECD3. About Axiomer ProQR is pioneering a next-generation RNA technology called Axiomer ® , which could potentially yield a new class of …
… and key opinion leaders and introduced next-generation Axiomer ® RNA technology platform. LEIDEN, the Netherlands, … trial in 2018. Beyond that, we are excited about the Axiomer ® platform technology we announced at our R&D day. … the event, the Company also introduced its next-generation Axiomer ® RNA technology platform, which has the potential to …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today announced … is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called …
… supports ProQR’s strategic focus on its proprietary Axiomer ® RNA editing technology platform and continued … of ProQR. “We look forward to continuing to advance our Axiomer RNA editing platform, with an initial focus on … is pioneering a next-generation RNA technology called Axiomer ® , which uses a cell’s own editing machinery called …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today announced … is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called …